Atheroplasty™
A New Era In Endovascular Revascularization
Enabling channel formation resulting in an image and treatment ready vessel
INTRAPLAQUE ATHEROPLASTY
A Paradigm Shift for Endovascular Crossing and Vessel Preparation
Restoring Blood Flow—The True Goal of Revascularization
Revascularization isn’t just a treatment – it’s the body’s natural way to heal. By restoring blood flow, we strive to address symptoms like claudication and prevent serious complications like amputation. AngioSafe is redefining revascularization with a safe, predictable, and effective approach.1
Three Mechanisms.All Morphologies.One Pass.
How Atheroplasty Works
- Lateral Intraplaque Cutting – stainless steel tip and cutting loop puncture, displace, and compress even moderately to severely calcified plaques.
- Plaque Compression – large profile centering system provides self-guided intraluminal positional control within the blood vessel. As the centering system traverses the lesion, the wings further dissect and compress the plaque locally in the lateral direction, without harming the vessel wall.
- Channel Formation – the immediate result from the use of the Santreva-ATK Endovascular Revascularization Catheter in femoropopliteal complex lesions is lumen gain and blood flow restoration through a channel, thereby revascularizing the previously ischemic distal zone.1
For years, we’ve thought about crossing as the goal. Santreva challenges that paradigm. Through the unique Atheroplasty mechanism of action, Santreva does more than traverse a complex occlusion – it creates a channel that initiates revascularization.
Craig Walker, MD, FACC, FACA, FACP, FSCAI, FASCI, FCCP, FICA
Founder, President, Medical Director and Interventional Cardiologist, Cardiovascular Institute of the South, Founder and Chairman, New Cardiovascular Horizons (NCVH), Louisiana, USA
Tackle the Plaque,Preserve the Wall
AngioSafe’s Atheroplasty can tackle complex lesions, including CTOs, irrespective of level of calcification or lesion length.1
Atheroplasty technology does not require any capital equipment and is the world’s first one-step endovascular revascularization platform, simplifying one of the most complex procedures in cardiovascular medicine.
1Banerjee, S. et al. Am J Cardiol. 2026 Mar 15:263:33-42

